Cargando…

Effects of methanol and formic acid on human platelet aggregation

BACKGROUND: Although ethanol is known to inhibit platelet aggregation, the effects of another variant of alcohol, methanol, have not been reported. The purpose of this study was to determine whether methanol and its metabolite, formic acid, affect Ca(2+) entry into and subsequent aggregation of plat...

Descripción completa

Detalles Bibliográficos
Autores principales: Marumo, Mikio, Wakabayashi, Ichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732411/
https://www.ncbi.nlm.nih.gov/pubmed/29246106
http://dx.doi.org/10.1186/s12199-017-0687-7
_version_ 1783286691028533248
author Marumo, Mikio
Wakabayashi, Ichiro
author_facet Marumo, Mikio
Wakabayashi, Ichiro
author_sort Marumo, Mikio
collection PubMed
description BACKGROUND: Although ethanol is known to inhibit platelet aggregation, the effects of another variant of alcohol, methanol, have not been reported. The purpose of this study was to determine whether methanol and its metabolite, formic acid, affect Ca(2+) entry into and subsequent aggregation of platelets in vitro. METHODS: Ca(2+) entry into and aggregation of human platelets were measured by spectrofluorometry using Fura-2/AM as an indicator and the light transmission method, respectively. RESULTS: Thrombin-induced platelet aggregation was significantly augmented by methanol at pharmacological concentrations (0.5–2%) in a concentration-dependent manner. Methanol at 2% significantly attenuated thapsigargin-induced platelet aggregation, which was not significantly affected by lower concentrations (0.5 and 1%) of methanol. Methanol (0.5–2%) did not significantly affect platelet aggregation induced by 1-oleoyl-2-acetyl-sn-glycerol (OAG), or Ca(2+) entry into platelets induced by thrombin, thapsigargin, or OAG. Platelet aggregation induced by thrombin, thapsigargin, or OAG was significantly inhibited by formic acid at toxic concentrations (0.01% or higher). Ca(2+) entry into platelets induced by thrombin or thapsigargin was also significantly inhibited by formic acid at 0.01% or higher, while that induced by OAG was not affected by formic acid at 0.005 and 0.01% and augmented by that at 0.02%. CONCLUSIONS: Methanol at pharmacological doses has diverse effects on platelet aggregation, depending on the aggregation stimuli, without affecting Ca(2+) entry into platelets. Formic acid at toxic concentrations has an inhibitory action on platelets aggregation, which was partly explained by the reduction of Ca(2+) entry into platelets.
format Online
Article
Text
id pubmed-5732411
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-57324112017-12-21 Effects of methanol and formic acid on human platelet aggregation Marumo, Mikio Wakabayashi, Ichiro Environ Health Prev Med Research Article BACKGROUND: Although ethanol is known to inhibit platelet aggregation, the effects of another variant of alcohol, methanol, have not been reported. The purpose of this study was to determine whether methanol and its metabolite, formic acid, affect Ca(2+) entry into and subsequent aggregation of platelets in vitro. METHODS: Ca(2+) entry into and aggregation of human platelets were measured by spectrofluorometry using Fura-2/AM as an indicator and the light transmission method, respectively. RESULTS: Thrombin-induced platelet aggregation was significantly augmented by methanol at pharmacological concentrations (0.5–2%) in a concentration-dependent manner. Methanol at 2% significantly attenuated thapsigargin-induced platelet aggregation, which was not significantly affected by lower concentrations (0.5 and 1%) of methanol. Methanol (0.5–2%) did not significantly affect platelet aggregation induced by 1-oleoyl-2-acetyl-sn-glycerol (OAG), or Ca(2+) entry into platelets induced by thrombin, thapsigargin, or OAG. Platelet aggregation induced by thrombin, thapsigargin, or OAG was significantly inhibited by formic acid at toxic concentrations (0.01% or higher). Ca(2+) entry into platelets induced by thrombin or thapsigargin was also significantly inhibited by formic acid at 0.01% or higher, while that induced by OAG was not affected by formic acid at 0.005 and 0.01% and augmented by that at 0.02%. CONCLUSIONS: Methanol at pharmacological doses has diverse effects on platelet aggregation, depending on the aggregation stimuli, without affecting Ca(2+) entry into platelets. Formic acid at toxic concentrations has an inhibitory action on platelets aggregation, which was partly explained by the reduction of Ca(2+) entry into platelets. BioMed Central 2017-12-16 2017 /pmc/articles/PMC5732411/ /pubmed/29246106 http://dx.doi.org/10.1186/s12199-017-0687-7 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Marumo, Mikio
Wakabayashi, Ichiro
Effects of methanol and formic acid on human platelet aggregation
title Effects of methanol and formic acid on human platelet aggregation
title_full Effects of methanol and formic acid on human platelet aggregation
title_fullStr Effects of methanol and formic acid on human platelet aggregation
title_full_unstemmed Effects of methanol and formic acid on human platelet aggregation
title_short Effects of methanol and formic acid on human platelet aggregation
title_sort effects of methanol and formic acid on human platelet aggregation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732411/
https://www.ncbi.nlm.nih.gov/pubmed/29246106
http://dx.doi.org/10.1186/s12199-017-0687-7
work_keys_str_mv AT marumomikio effectsofmethanolandformicacidonhumanplateletaggregation
AT wakabayashiichiro effectsofmethanolandformicacidonhumanplateletaggregation